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The replication of the RNA of vesicular stomatitis virus (VSV) defective
interfering (DI) particles was established in a defined cell-free system. The
transition from synthesis of only the DI-leader RNA to replication of the full-
length DI RNA was effected in the system by newly synthesized VSV proteins
and occurred in the absence of VSV helper virus. Both positive- and negative-
polarity full-length DI RNA were synthesized. Furthermore, the products ofRNA
replication associated with newly synthesized viral proteins to form complexes
that were indistinguishable from authentic DI particle nucleocapsids on the basis
of buoyant density and resistance to ribonuclease digestion. The DI-leader RNA
did not form ribonuclease-resistant structures. We conclude that this in vitro
system successfully executes many of the reactions ofVSV DI particle replication
and assembly.
One of the major differences between the two
RNA synthetic reactions, transcription and rep-
lication, that are carried out by the negative-
strand RNA virus, vesicular stomatitis virus
(VSV), is that replication requires viral protein
synthesis, whereas transcription does not. The
template for both RNA synthetic reactions is the
negative-strand genomic RNA (4 x 106 daltons)
in the form of a nucleocapsid structure, that is,
coated with the nucleocapsid protein, N, and
associated with the phosphoprotein, NS, and the
large protein, L, which are components of the
RNA polymerase. This structure is capable of
carrying out transcription of the genome to yield
leader RNA and the five VSV mRNAs (2, 10).
At present, we do not known precisely what
protein or proteins are required to effect and
maintain the transition from the synthesis of
leader RNA and the discrete mRNAs (tran-
scription) to the synthesis of a complete read-
through product to yield a full-genome-sized
plus strand RNA, which is subsequently used as
the template for synthesis of the progeny nega-
tive-strand RNA genomes (replication). In cells,
the full-length genomic RNA products of repli-
cation are found only in the form of nucleocap-
sids and are therefore resistant to digestion by
ribonucleases, whereas the mRNA products of
transcription are completely sensitive to diges-
tion by nucleases (30). Since the products of
replication are protein-coated RNAs, it has been
postulated by numerous workers that a require-
ment for the nucleocapsid structural protein, N,
may constitute the need for continuous protein
synthesis in negative-strand virus RNA replica-
tion. It has been proposed that N protein may
play a specific role in catalyzing the transition
from transcription to replication by binding to a
site in leader RNA which may be the nucleation
site for encapsidation (1, 14, 21). This event
would be dependent on the availability of N
protein and would determine the balance be-
tween replication and transcription. It has been
proposed specifically that N functions to sup-
press a termination signal at the end ofthe leader
gene and that the binding of N within leader
simultaneously starts nucleocapsid assembly (5,
21).
It is also possible that other newly synthesized
proteins are required to promote replication. For
example, the switch to replication may require a
newly synthesized L molecule, an L molecule
that has been modified by association with a
newly synthesized form of the phosphoprotein
NS, which has been shown to exist in two
distinct phosphorylated forms (6, 15), or both.
Additionally, it is possible that host factors may
play a role in replication (24).
To investigate the requirement for protein
synthesis in RNA replication, a defined in vitro
system has been designed that supports both
transcription and replication of the negative-
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strand genomic RNA of the rhabdovirus, VSV
(8). The system consists of three components: (i)
purified VSV nucleocapsids as templates for
RNA synthesis; (ii) an mRNA-dependent rabbit
reticulocyte lysate to support protein synthesis;
and (iii) purified VSV mRNAs to direct protein
synthesis, if required. By using this combination
of components, the level of viral protein synthe-
sis can be controlled as desired by omission or
addition of various amounts of viral mRNA. In
this system, replication of the genomic RNA is a
function of the level of viral protein synthesis,
thereby allowing us to investigate the protein
requirements for replication.
Since VSV nucleocapsid templates carry out
both RNA transcription and replication in this
system, we chose to extend our studies of repli-
cation by using a defective interfering (DI) parti-
cle as the template for RNA synthesis to focus
solely on the process of RNA replication. The
RNA of the DI particle we selected (called DI-T,
VSI-DI 0.25; genome molecular weight, 0.9 x
106) contains only the 5' 25% of the standard
virus genome; it completely lacks genetic infor-
mation for the N, NS, M, and G proteins and
contains approximately half of the information
for the L protein (19, 31). This DI particle,
therefore, does not direct mRNA synthesis. The
major RNA product made in vitro by the DI
particles generated from the 5' end of the
genome is a 46-base RNA encoded by the ex-
treme 3' end of the DI particle RNA and called
the DI-leader RNA (9, 28, 29). In cells coinfect-
ed with DI particles and standard helper virus,
both the DI-leader and genome-length DI RNA
of positive and negative polarity are synthesized
(20, 25, 26). An important feature of the DI
particle RNA, for our purposes, is that the 3'
terminus of the positive strand (the template for
negative-strand replication) is identical to the 3'
terminus of the standard VSV positive strand
(13, 18). In addition, the 5' and 3' termini of the
DI RNAs are complementary. Therefore, the 3'-
terminal sequences of both positive and negative
RNA strands, which are the initiation sites for
RNA synthesis, are identical. Thus, this DI
particle constitutes an excellent template for
investigating replication, since it is small, con-
taining only a quarter of the genome, and does
not direct mRNA synthesis, and yet it has the
correct sites for initiation of replication and can
replicate efficiently in cells coinfected with in-
fectious VSV. It is assumed that the requirement
for helper virus is as a source of mRNAs to
direct viral protein synthesis.
In this report we describe the replication in
vitro of full-length DI particle RNA of both
positive and negative polarity. The replication of
the DI RNA occurs in the absence of helper
virus and only requires viral protein synthesis.
Additionally, the full-length DI RNAs produced
in this system are encapsidated with protein to
form nucleocapsids that are indistinguishable
from authentic DI nucleocapsids on the basis of
buoyant density and resistance to ribonuclease
digestion.
MATERIALS AND METHODS
Cell cultures and virus. Virus was propagated in
monolayer cultures of BHK-21/13 cells as described
previously (33). The Indiana serotype (San Juan strain)
of VSV was used as standard VSV. Stocks of the DI
particle, DI-T (VSI-DI 0.25; 5' 25% of VSV genome
[31]), were generously provided by R. Lazzarini (Na-
tional Institutes of Health, Bethesda, Md.).
Preparation of nucleocapsids. Intracellular DI parti-
cle nucleocapsids were prepared by infection of BHK
cells with standard VSV at a multiplicity of infection of
1 and VSV DI particles (VSI-DI 0.25 was used in all
cases) at multiplicities indicated. DI nucleocapsids
were extracted from mixedly infected cells by Dounce
homogenization, and DI particle nucleocapsids were
separated from standard virus nucleocapsids by veloc-
ity sedimentation in 15 to 30% sucrose gradients (2 h at
38,500 rpm; Beckman SW40 rotor). The band of DI
nucleocapsids was collected and sedimented through
25% sucrose (2 h at 44,000 rpm; Beckman SW50
rotor), and the pelleted nucleocapsids were suspended
in HGD buffer (10% glycerol, 10 mM N-2-hydroxyeth-
ylpiperazine-N'-2-ethanesulfonic acid [HEPES], pH
7.6, 2 mM dithioerythritol).
Analysis of template RNA. The amount of unlabeled
nucleocapsid template RNA added to each reaction
was quantitated by parallel preparation of [3H]uridine-
labeled templates with each preparation of unlabeled
templates. The specific activity of labeled template
RNA was quantitated, and this figure was used to
calculate the amount of template RNA in unlabeled
preparations made under identical conditions. Similar-
ly, the ratio of positive to negative strand full-length
DI RNA in template preparations was determined by
densitometric scanning of fluorograms or by excision
of appropriate bands from gels as described below. In
all experiments where DI particle nucleocapsid tem-
plates were used, approximately 1,000 pg of DI parti-
cle template RNA was added per 25-,ul reaction.
In vitro synthesis of viral RNA and proteins. Viral
RNA and protein synthesis were carried out in the
presence of a micrococcal nuclease-treated rabbit re-
ticulocyte lysate as described previously (8) except
that the incubation times were varied as indicated in
the figure legends.
Analysis of RNA products. 3H-labeled products were
analyzed by electophoresis on 1.75% agarose-6 M
urea gels as described previously (32) or on 20%o
polyacrylamide slab gels according to the method of
Laemmli and Faure (16). DI-leader RNA (character-
ized and kindly provided by L. A. Ball, University of
Wisconsin, Madison, Wis.) and DI particle template
RNA were electrophoresed as internal markers in all
gels, and their positions are indicated. After electro-
phoresis, gels were fixed with 10% acetic acid and
subjected to fluorography according to the method of
Laskey (17). The resulting fluorograms were scanned
to quantitate the intensity of bands by using an LKB
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2202 Ul trascan densitometer interfaced with an Apple
II computer. Preflashed film was used to ensure a
linear response to low levels of radioactivity. Addi-
tionally, a calibration curve of the linear response
range for film darkening was constructed and used to
ensure that intensity scans were always carried out in
the linear range. To measure the amount of radioactiv-
ity in 3H-labeled RNA species, appropriate bands
were cut out of a dried gel, using the fluorogram as a
guide. The dried gel fragments were dissolved in NCS
solubilizer (Amersham Corp.) at 60°C for 16 h before
analysis by liquid scintillation spectroscopy.
Materials. [5,6_3H]UTP (specific activity, 35 Ci/
mmol) was from ICN Pharmaceuticals.
RESULTS
Preparation of DI particle nucleocapsids. VSV
DI paticles lack complete information for the
structural genes, so it is necessary to propagate
them by mixed infection of cells with standard
VSV helper virus. The following method was
used to prepare DI particle nucleocapsid prepa-
rations that did not contain standard virus nu-
cleocapsids to use as templates for RNA replica-
tion reactions. Mixed infections to propagate DI
particles were carried out at multiplicities that
yielded the greatest amount of DI particle nu-
cleocapsids while giving minimum yields of stan-
dard virus without totally inhibiting the infec-
tion. Optimum multiplicities were determined by
assaying the types of RNA synthesized in BHK
cells infected with standard virus at a multiplic-
ity of infection of 1 while the input of DI
particles varied. As shown in Fig. 1, decreasing
dilutions of the DI particle preparation gave high
yields ofDI particle RNAs, whereas synthesis of
standard 40S virion RNA was greatly dimin-
ished. These RNAs were analyzed on 1.75%
agarose-urea gels, which can resolve the posi-
tive and negative strands of the DI particle
genomic RNAs (11). The dilution of DI particles
which we subsequently employed in our experi-
ments was 1:3,800, a dilution which reduced the
12-h yield of standard virus by 98.6%, using the
Cooper and Bellett assay (7).
DI particle nucleocapsids were extracted from
mixedly infected cells and separated from stan-
dard virus nucleocapsids by velocity gradient
sedimentation. The purity of the RNAs isolated
by this procedure is shown in Fig. 2. Only the
positive- and negative-strand RNAs of DI parti-
cle nucleocapsids were detectable even after
overexposure of fluorograms of gels on which
these RNAs were analyzed. These results indi-
cated that our preparations of DI particle nu-
cleocapsids were essentially free of standard
VSV nucleocapsids and mRNA. Further evi-
dence that the preparations were devoid of de-
tectable standard VSV nucleocapsids came from
an analysis of the RNA products synthesized by
these preparations in vitro (see below).
MIXED INFECTION
1 2 3 4
40S RNA-




FIG. 1. Agarose-urea gel electrophoresis of RNA
from BHK cells infected with standard VSV and VSV
DI particles. BHK cells were infected with standard
VSV at a multiplicity of infection of 1 and with VSV
DI particles at dilutions of: lane 1, 1:10,000; 2, 1:7,500;
3, 1:5,000; and 4, 1:2,500. RNA labeled with [3H]uri-
dine from the start of infection was harvested at 12 h
postinfection from cytoplasmic extracts and analyzed
by electrophoresis in 1.75% agarose gels containing 6
M urea.
Analysis of RNA products: effects of protein
synthesis. RNA synthesis was directed by the DI
particle templates in the in vitro system, either
in the absence or presence of concomitant viral
protein synthesis programmed by added VSV
mRNA. The products of the reaction were ana-
lyzed by electrophoresis on a 1.75% agarose gel
containing 6 M urea (Fig. 3). This gel system
separated the DI particle genome-size positive-
and negative-strand RNA as well as retaining the
46-base DI-leader RNA and thereby allowed
simultaneous quantitation of both DI particle-
specific products.
The major product synthesized by the VSV DI
particle nucleocapsids in the absence of viral
protein synthesis was the 46-base DI-leader
RNA (Fig. 3, lane 2). This finding confirmed
previous reports that the DI-leader is the major
product transcribed from the genomes of puri-
fied DI particles (9). In the presence of VSV
mRNA translation, two distinct changes in the
pattern ofRNA products were observed: (i) full-






particle genomic RNA as well. Analysis of pro-
tein synthesis in this system (data not shown) (8)
has demonstrated that all five of the VSV-
specific proteins are synthesized. Synthesis of
the VSV proteins is linear with time for up to 3 h
and approximately 5 to 10 pmol of protein is
made during 180 min in a 25-,ul reaction. To test
directly whether this transition in the pattern of
RNA products was due to viral protein synthesis
or was a direct effect of the addition of viral
mRNA, protein synthesis was inhibited by the
addition of cycloheximide or cycloheximide and
anisomycin. Under these conditions, where pro-
tein synthesis was inhibited by more than 99%,
no DI full-length RNA was synthesized and the
amount of DI-leader RNA made increased (Fig.
3, lane 4). These results showed that viral pro-
tein synthesis is responsible for enabling the DI
Di RNA PRODUCTS
FIG. 2. Analysis of RNA from DI particle nucleo-
capsid preparations. DI particle nucleocapsids were
isolated from cytoplasmic extracts of BHK cells in-
fected with standard VSV at a multiplicity of infection
of 1 and DI particles at a dilution of 1:3,800 by two
cycles of velocity sedimentation. RNA was extracted
from nucleocapsids and analyzed as described in the
legend to Fig. 1. Lane 1, Marker RNA from DI particle
virions; 2, RNA from DI particle nucleocapsids (fluor-
ogram exposed 3 days); 3, same as lane 2 except that
the fluorogram was exposed for 7 days.
negative polarity appeared (Fig. 3, lane 3),
which comigrated with marker template DI par-
ticle RNA (Fig. 3, lane 5); and (ii) there was a
marked reduction in the amount of DI leader
that was produced. The appearance of the full-
length RNAs was dependent on the presence in
the reaction mixture of all four ribonucleoside
triphosphates. This finding indicated that these
products were synthesized de novo and that
they were not generated by terminal incorpo-
ration or exchange of labeled nucleotide.
At high concentrations of DI particle nucleo-
capsids, the synthesis of full-length DI RNA
became less efficient and, in some experiments,
was not completely dependent on the addition of
viral mRNA. The reasons for this are unknown,
but one possibility is that the high concentration
of viral proteins contributed by the nucleocapsid
preparation was able to support a limited
amount of RNA replication.
The data presented above suggested that pro-
tein synthesis directed by VSV mRNAs was
responsible for the transition from synthesizing
only leader RNA to synthesizing full-length DI
1 2 34 5







FIG. 3. Agarose-urea gel electrophoresis of RNA
products synthesized by DI particle nucleocapsids in
vitro. RNA products were labeled with [3H]UTP in the
cell-free system programmed with the following com-
ponents: lane 1, no DI templates; 2, DI templates, no
VSV mRNA; 3, DI templates, VSV mRNA; 4, DI
templates, VSV mRNA, and cycloheximide (50
,g/ml); 5, marker DI template RNA. Incubation was
for 180 min at 4°C. RNA was extracted and analyzed
as described in the legend to Fig. 1.
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particle nucleocapsids to carry out the synthesis
of full-length RNA copies.
Quantitation of RNA products. The reduction
in DI-leader synthesis under conditions where
the replication offull-length RNA was occurring
prompted us to quantitate the amounts of these
two products. The relative amounts of full-
length DI RNA and DI-leader RNA were quanti-
tated by scanning laser densitometry of fluoro-
grams of gels of the separated products. The
data represented in Table 1 show that for each 1
mol of full-length DI product (both positive and
negative strand) produced in the presence of
protein synthesis, approximately 100 mol of DI-
leader was synthesized. In the absence of pro-
tein synthesis, threefold more DI-leader was
synthesized than in the presence of protein
synthesis. If cycloheximide was added to inhibit
protein synthesis, more leader was made, al-
though less than was seen in the absence of
added mRNA and inhibitor. These results are in
agreement with the observation that the amount
of negative-strand leader in infected cells is
increased in the presence of cycloheximide (5).
The ratio of positive to negative strand for
full-sized DI RNA product was compared to this
ratio for the input template nucleocapsid RNAs.
Averaged data from five separate experiments
showed that after 90 min of synthesis, the prod-
uct DI full-length RNA was composed of ap-
proximately 42% negative-strand RNA and 58%
positive-strand RNA. Input template prepara-
tions contained an average of 57% negative and
43% positive strands. These data showed that
synthesis of progeny full-sized RNA in this
system closely reflected the ratio of input tem-
plate RNAs at early times in the reaction. This is
the result one would predict if the full-length DI
product was copied from the input template. At
later times in the reaction (3 h), the ratio of
positive- to negative-strand products became
approximately equal. This finding may suggest
that RNAs synthesized at early times can serve
as new templates for replication at later times.
Additionally, the absolute amount of input tem-
plate RNA was calculated and compared to the
amount of DI full-length RNA product by exci-
sion of appropriate bands from gels. Approxi-
mately 1,000 pg of template RNA was added per
25-IlI reaction and approximately 400 to 700 pg
of DI genome-length RNA was produced.
Kinetics of RNA synthesis. To investigate the
decrease in DI-leader synthesis with the onset of
RNA replication, we analyzed the kinetics of
appearance of both DI-leader and full-length DI
RNA. For these experiments, the synthesis of
DI-leader RNA was analyzed by electrophoresis
of samples on 20%o acrylamide gels followed by
densitometric scanning of fluorograms of dried
gels (Fig. 4). Initially, DI-leader was produced at
TABLE 1. Relative molar amounts of DI particle
RNA products
Molar amt
Reaction DI genome- DI-leader
sized RNAb RNA
DI nucleocapsids alone 0 328
DI nucleocapsids + VSV mRNA 1 93
DI nucleocapsids + VSV mRNA 0 114
+ cycloheximide _I
a Relative molar amounts were calculated by densi-
tometric scanning of fluorograms of [3H]UTP-labeled
products separated by gel electrophoresis. Uridine
contents of 6.5% for DI-leader (28, 29) and 31% for DI
particle genome RNA (27) were used in making calcu-
lations.
b Both positive- and negative-strand genome-sized
RNAs were included in this calculation.
the same rate whether mRNA had been added to
program viral protein synthesis or not. Howev-
er, after 20 to 40 min, while DI-leader continued
to accumulate at a linear rate in the absence of
protein synthesis, there was a marked decrease
in its rate of accumulation in the presence of
ongoing protein synthesis. Indeed, there was
little additional DI-leader RNA accumulation
after 40 min in reactions with ongoing protein
synthesis.
A corresponding kinetic analysis of full-length
DI RNA synthesis showed that full-size RNA
was not detectable until approximately 60 to 90
min after the start of the reaction (Fig. 5). The
accumulation of this product was not linear with
time, and the major accumulation of full-length
DI RNA occurred abruptly 2 to 3 h after the start
of the reaction.
Association of RNA products with protein.
Studies ofRNA replication in infected cells have
shown that replication is dependent on protein
synthesis and that both positive- and negative-
strand genome-sized RNAs are found only in the
form of nucleocapsids, never as naked RNA.
Having demonstrated that full-sized DI particle
RNA could be synthesized in vitro and that its
production was dependent on protein synthesis,
we next examined the ability of the RNA prod-
ucts to associate with newly synthesized pro-
teins. The association was assayed in two ways.
First, the behavior of the RNA products in CsCl
density gradients was analyzed. The 3H-labeled
DI full-length product banded in CsCl gradients
at the same position as marker DI nucleocapsids
(data not shown), indicating that the RNA was
not naked but was associated with protein and,
also, that the RNA/protein ratio was approxi-
mately the same as that of authentic nucleocap-
sids. Next, the susceptibility of the RNA prod-
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After 10 min at 23°C ethylene glycol-bis(Q-amin-
oethyl ether)-N,N-tetraacetic acid was added to
inhibit further nuclease activity. The reactions
were terminated, and the RNA was extracted
and analyzed in the same manner as the undi-
gested samples. Nuclease digestion of mRNA
transcription products synthesized in the in vitro
system by VSV virion nucleocapsids was per-
formed under identical conditions to test wheth-
er the micrococcal nuclease was active in these
conditions. The results of this experiment are
presented in Fig. 6. Only the full-length DI RNA
products were resistant to nuclease digestion
(Fig. 6, lane 6). The DI-leader RNA was digest-
ed by micrococcal nuclease even when made in
the presence of ongoing protein synthesis. As
expected, the VSV mRNAs synthesized by
nucleocapsids from infectious virions were also
SYNTHESIS OF DI RNAs
A.. 1minutes 6 9 2 8
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FIG. 4. Kinetics of accumulation of DI-leader
RNA. (A) DI-leader RNA synthesis was compared in
cell-free reactions programmed with DI templates to
which VSV mRNA was (b,d, and f) or was not (a,c,
and e) added. RNA products synthesized in the pres-
ence of [3H]UTP added at the start of the reaction
were analyzed at 20 (a,b), 40 (c,d), or 80 (e,f) min by
electrophoresis on 20% acrylamide gels. 3H-labeled
product comigrated exactly with marker DI-leader
(position indicated). (B) Fluorograms of the dried gels
were scanned with a laser densitometer, and the
relative amounts of product synthesized during each
time interval were plotted.
examined. RNA products were synthesized in
vitro in the presence or absence of viral protein
synthesis as described for Fig. 3. After 90 min of
incubation, the reaction mixtures were divided
in half. Half of each reaction was immediately
terminated by the addition of sodium dodecyl
sulfate. The RNA was extracted and analyzed
by gel electrophoresis. The other half of each
reaction mixture was digested with micrococcal
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FIG. 5. Kinetics of appearance of full-lengtb DI
particle RNAs. (A) [3H]UTP-labeled products synthe-
sized in the in vitro system programmed with DI
templates and added VSV mRNA were analyzed at 60,
90, 120, and 180 min after the start of the reaction by
electrophoresis as described in the legend to Fig. 1. A
small amount of positive- and negative-strand full-
length product was detectable at 60 miin on the original
fluorogram, but was not of great enough quantity to be
discerned on subsequent photographic exposure. Lane
M shows marker DI template RNAs. (B) Fluorograms
of the dried gel were scanned as described in the
legend to Fig. 4, and the kinetics of appearance offull-
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The results presented above demonstrate that
it is possible to carry out the replication of full-
length VSV DI particle RNAs of both positive
*-G and negative polarity in vitro. The ratios of
@ ZN positive to negative strand progeny RNA closely
reflected the ratio of input nucleocapsid tem-
NS plate RNA at early times in the reaction. At later
M times (3 h), approximately equal amounts of
positive and negative strand RNAs were pro-
duced. The DI particle nucleocapsid templates
were able to make the transition from synthesiz-
ing only the DI-leader RNA in vitro to synthesiz-
ing full-length, DI genome-sized RNA by viral
protein synthesis. This transition was blocked
by inhibitors of protein synthesis. These results
show that DI RNA replication is regulated by
viral protein synthesis in this system, as it is in
Aeader. ~~~~infected cells.
The events involved in replication of DI RNA
can be considered in more detail. In the absence
o 0 + + 0 of protein synthesis, the DI-leader is the only
0 00+ 0 product synthesized by the DI nucleocapsid
template. A strong termination signal is present
sensitivity of products synthe- at the end of the leader gene. Theoretically, any
nucleocapsids. [3H]UTP-labeled read through or elongation of product beyond
iesized by DI particle nucleocap- the DI-leader boundary can be considered repli-
ystem during a 90-min incubation cation. The successful elongation of the product
) added VSV mRNA (lanes 1 and to yield a full genome-sized RNA, however, may
NA (lanes 2 and 6), added VSV be a process involving different protein require-
ximide (50 ,ug/ml) (lanes 3 and 7). ments than the initial read-through event. For
oducts synthesized by standard example, the transition from transcription to
with no added VSV mRNA (lanes eplcathemayrequire tic orichiometo
zed before (lanes 1 through 4) or replication may require catalytic or stoichiomet-
,h 8) digestion with micrococcal ric (or both) amounts of a certain protein(s) or a
for 10 min at 23°C by gel electro- short-lived intermediate (see above), whereas
d in the legend to Fig. 1. the efficient elongation of product to yield full-
length progeny may require only a constant
supply of the nucleocapsid protein N. We have
not assayed directly for the former event in this
d by the nuclease (Fig. 6, lane system at this time. Rather, we chose to assay
only for the complete read-through product, a
mmonstrate not only that full- full-length DI molecule. Therefore, based on the
>- and negative-strand RNAs studies presented here, we can say that for
this system in a protein syn- efficient synthesis of full-length product to oc-
eaction, but also that the pro- cur, a certain concentration of viral protein must
tble to associate with these be available. The findings reported here are
RNAs to form structures that consistent with the requirement for continuous
I CsCl, that coband in CsCl protein synthesis to maintain genome RNA syn-
with authentic DI particle nu- thesis in VSV-infected cells (23, 33).
hat are completely resistant to A striking aspect of the quantitation of RNA
clease. These properties are products was the finding that as protein synthe-
ucleocapsids and suggest that sis was initiated in the system and the synthesis
e formed in this in vitro sys- of full-length DI RNA occurred, the amount of
analyses of the viral proteins DI-leader RNA decreased threefold. When the




were compared in the presence and absence of
viral protein synthesis, it was observed that the
rate of accumulation was similar for the first 20
min of the reaction. After that time, however,
while DI-leader continued to accumulate at a
linear rate in the absence of protein synthesis,
there was a marked decrease in its accumulation
in the presence of protein synthesis. The appear-
ance of full-length DI RNA could not be detect-
ed until approximately 60 to 90 min in reactions
in which protein synthesis was initiated at time
0. These data showed that the sharp decrease in
the rate of accumulation of DI-leader RNA was
followed by the appearance of full-sized DI
RNA. These two events, however, did not occur
until approximately 40 min after the start of the
reaction.
In considering these results, it is important to
note that viral protein synthesis was being pro-
grammed from the start of the reaction and,
therefore, that no preexisting pool of free virus
proteins existed. One explanation for the results
of these kinetic studies may be as follows. After
protein synthesis is initiated in the system and
proteins begin to accumulate, a necessary con-
centration of protein is achieved such that the
transition can be made from termination at the
end of the DI-leader to production of full-length
product. As this occurs, one might predict a
decrease in the appearance of discrete DI-leader
RNA as this molecule is elongated to produce
the full genome-sized product. However, this
explanation can account for only a small part of
the decrease in accumulation of discrete DI-
leader (Table 1). We do not know what other
factors may be involved. It is possible that the
rate of initiation in the system slows down as the
result of production of some new viral protein,
or perhaps the involvement of polymerase mole-
cules in elongation of the DI product restricts
the amount of polymerase available for initia-
tion. Another possibility is that there is a pause
at the junction between DI-leader and the rest of
the DI genome, which may result in a slowing of
polymerase movement and new initiation
events. Iverson and Rose (12) have shown that
there is a distinct pause of approximately 5 min
in the rate of VSV RNA transcription at each
intercistronic junction. Taken together, the sim-
plest explanation of these results and one that is
consistent with our knowledge of replication in
the infected cell is that the transition to replica-
tion of full-length RNA in this system requires
not simply ongoing protein synthesis but rather
the availability of a certain concentration of viral
protein before it is possible to detect the synthe-
sis of the full-sized RNA.
The work described above also demonstrated
that the full-length DI positive- and negative-
strand RNAs, made in a protein synthesis-de-
pendent reaction, could associate with the pro-
teins synthesized concomitantly in the system.
The RNA products banded in CsCl at the same
buoyant density as marker DI nucleocapsids,
indicating that the RNA was associated with
proteins and that the RNA/protein ratio was the
same as that of authentic nucleocapsids. More-
over, both the full-length positive- and negative-
strand RNA products were completely resistant
to digestion with ribonuclease. Our data showed
that all of the replicated product was protected
from nuclease digestion. Since the electropho-
retic migration of the RNAs after nuclease diges-
tion was the same as that before, these data
suggest that, within the limits of this assay, the
full-length RNAs were fully protected. These
findings show that the newly synthesized RNA
and proteins associate to form structures that
resemble authentic nucleocapsids.
Quantitation of full-length DI product RNA
demonstrated that approximately 1.4 to 2.1 pmol
of nucleotide was synthesized in a 25-,lI reac-
tion. In this same reaction, approximately 4.8
pmol of viral protein was made, of which 1.7
pmol was N protein. Assuming that the size of
the DI genome RNA is approximately 3,000
bases, these data show that there are roughly
2,500 to 3,600 N molecules available per mol of
DI product RNA. Bishop and Roy (3) have
calculated that there are approximately 2,000 N
molecules per standard VSV genome. The DI
genome is approximately one-quarter this size
and, based on the above figure, should require
approximately 500 N molecules to coat each full-
size DI genome. Thus, the replication system
reported here produces sufficient N protein to
coat the progeny DI RNAs. This finding is
consistent with the fact that all the DI full-length
RNA is nuclease resistant, and it shows that this
system can produce viral proteins and RNA in
quantities appropriate to successfully carry out
RNA replication and nucleocapsid assembly.
The DI-leader RNA, in contrast to the full-
length DI RNA, however, was not resistant to
digestion with ribonuclease. A model has been
put forward (5, 21) which proposes that the
availability of N protein controls the balance
between replication and transcription by the
binding of N protein to a site in leader RNA,
which thereby attenuates the termination at the
end of leader and allows read through while
simultaneously creating a nucleation site for
encapsidation; failure to bind N results in termi-
nation and release of leader is a discrete mole-
cule. We observed that the accumulation of free
DI-leader RNA was decreased in the presence of
protein synthesis and full-length RNA replica-
tion. Moreover, we have shown that all full-
length DI RNA is encapsidated with protein,
whereas free leader is not. These findings are
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compatible with, but do not prove, the idea that
N protein binding to a leader RNA can result in
elongation to yield genome-length RNA, where-
as failure of N to interact with leader results in
termination and release of free leader. In con-
trast to our finding that free leader was not
encapsidated in our system, Blumberg and Kola-
kofsky (4) reported that approximately three-
quarters of the total intracellular leader RNA
was encapsidated. In relation to the model pro-
posed, their finding suggests that association of
N with leader may not always result in read
through or that encapsidation of free leader may
occur after release from the template in the
infected cell, or both. We suggest that in our in
vitro system, RNA synthesis occurs under con-
ditions where protein concentration may not be
as great as in the infected cell. Under these
circumstances, it may be that free leader is
revealed as a less efficient competitor for N
protein than a nascent leader molecule still at-
tached to its template.
In conclusion, an in vitro system has been
established which supports the synthesis of full-
length VSV DI particle RNA and carries out its
encapsidation to form nucleocapsids. In this
system, the transition from synthesis of only the
DI-leader RNA, a transcription event, to the
replication of full-length DI RNA is made as a
function of viral protein synthesis, which can be
controlled by omission or addition of viral
mRNA. Thus, individual VSV mRNAs can be
added alone or in combination to program pro-
tein synthesis, and the effects of these proteins
on the transition to RNA replication can be
evaluated. This approach provides a method for
assaying the involvement of individual proteins
in the process of RNA replication.
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